Lixisenatide (Lyxumia, Adlyxin, ZP10A peptide, AVE0010) is a once-daily short-acting glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with an IC50 of 1.4 nM for the human GLP-1 receptor in receptor binding studies.
Related Prodcuts:
Dynorphin A (1-13); Deslorelin; Gonadorelin; Gonadorelin acetate; Sermorelin; Sermorelin Acetate; Etelcalcetide; DSIP; Angiotensin acetate; Epithalone; Buserelin; Cilengitide; Cilengitide trifluoroacetate; Tesamorelin; Selank; ACTH (1-39) Seractide; Ipamorelin